Taysha Gene Therapies, Inc.
Biological Products, (No Diagnostic Substances) · Dallas, TX, United States
- PrincipalsKamran AlamCHIEF FINANCIAL OFFICERSean P. NolanChief Executive OfficerSukumar NagendranPresident and Head of R&D
- CompanyTaysha Gene Therapies, Inc.Dallas, TX, United States
- Phone line+1 (214) 612-0000General business
Taysha Gene Therapies, Inc. is an SEC-registered Nasdaq-listed company (ticker TSHA) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Finance
Kamran AlamCHIEF FINANCIAL OFFICER
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Kamran Alam — CHIEF FINANCIAL OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sean P. Nolan — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sukumar Nagendran — President and Head of R&D
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
enGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capability